'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Pertussis (Whooping Cough) to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Pertussis (Whooping Cough) to Infectious Disease Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Pertussis (Whooping Cough) Therapeutics Clinical Trials 33
Prominent Drugs 35
Clinical Trial Profile Snapshots 36
Appendix 263
Abbreviations 263
Definitions 263
Research Methodology 264
Secondary Research 264
About GlobalData 264
Contact Us 265
Source 265
List of Tables
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Pertussis (Whooping Cough) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Pertussis (Whooping Cough) to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 17
Pertussis (Whooping Cough) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Pertussis (Whooping Cough) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Pertussis (Whooping Cough) to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 21
Pertussis (Whooping Cough) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Pertussis (Whooping Cough) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials by Phase, 2018* 24
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Pertussis (Whooping Cough) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
List of Figures
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Pertussis (Whooping Cough) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Pertussis (Whooping Cough) to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
Pertussis (Whooping Cough) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Pertussis (Whooping Cough) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Pertussis (Whooping Cough) to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 20
Pertussis (Whooping Cough) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Pertussis (Whooping Cough) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
Pertussis (Whooping Cough) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Pertussis (Whooping Cough) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Pertussis (Whooping Cough) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
GlobalData Methodology 264